Novel hybrid nocodazole analogues as tubulin polymerization inhibitors and their antiproliferative activity

We describe the design, synthesis and SAR profiling of a series of novel combretastatin-nocodazole conjugates as potential Anticancer agents. The thiophene ring in the nocodazole moiety was replaced by a substituted phenyl ring from the combretastatin moiety to design novel hybrid analogues. The hydroxyl group at the ortho position in compounds 2, 3 and 4 was used as the conformationally locking tool by anticipated six-membered hydrogen bonding. The bioactivity profiles of all compounds as tubulin polymerization inhibitors and as antiproliferative agents against the A-549 human lung Cancer cell line were investigated Compounds 1 and 4 showed μM IC50 values in both assays.